Neeraj Chopra decides to end 2021 season, says focus shifted to packed 2022
New Delhi, Aug 26: Olympic gold medallist javelin thrower Neeraj Chopra has decided to end his 2021 competition season due to a "packed schedule of travel and a bout of illness" and vowed to comeback stronger in a busy 2022.
"The packed schedule of travel and a bout of illness has meant I have not been able to resume training since Tokyo...," Neeraj wrote on an instagram post.
"...therefore, along with my team, have decided to cut short by 2021 competition season to be able to take some time off, recharge and come back stronger for a packed 2022 calendar which includes the World Championships, Asian Games and Commonwealth Games."
The 23-year-old Chopra, who had ended India's 100-year wait for a track and field medal in the Olympics with a gold medal at Tokyo, has been on a busy schedule since his return to the country, leaving him exhausted. He also suffered a slight bout of fever.
Chopra, who has been attending various felicitation functions across the country, was overwhelmed by all the support.
"Firstly, I want to thank everyone for the love and affection I have received since I came back from Tokyo. I have honestly been overwhelmed by the support from across the country and beyond, and am short of words to express my gratitude to you all," he said.
"I have been encouraged by all the support to Indian athletics over these past few weeks and would urge you all to keep supporting India and Indian athletics in the months and years to come."
Chopra had become only the second Indian to win an individual gold in the Olympics when he produced a second round throw of 87.58m in the finals at Tokyo.
View this post on Instagram
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Patanjali, Chennai-based institution to jointly conduct clinical trials of Ayurvedic medicines
Haridwar, May 3: Patanjali Research Foundation and Chennai-based SRM Centre for Clinical Trials and Research will now jointly conduct clinical trials on Ayurvedic medicines.
A Memorandum of Understanding was signed between the two institutions to this effect here on Friday.
Patanjali Yogpeeth general secretary Acharya Balkrishna said the MoU will prove to be a milestone in the history of Ayurveda.
Head of Patanjali Research Foundation Anurag Varshney said with the help of this MoU, both the institutions will together present the effectiveness of Ayurvedic medicines to the world in an evidence-based manner and prove their usefulness in treating various diseases.
Dean-Research, SRM CCTR Nitin M Nagarkar expressed happiness that the agreement will play an important role in giving global recognition to India's ancient system of medicine.
